Retatrutide significantly reduced body weight (mean difference [MD]: 14.33%), body mass index (MD: 5.38), waist circumference (MD: 10.51 cm), fasting plasma glucose (MD: 23.51 mg/dL), hemoglobin A1c (MD: 0.91%), and systolic and diastolic blood pressure (MD: 9.88 mm Hg and 3.88 mm Hg, respectively), all with P values 35 kg/m 2 , frequently resulting in diabetes remission and improvement in associated obesity-related conditions
The timeframe for seeing results with Semaglutide can vary from person to person, depending on your unique metabolism, dosage, and how closely you follow our recommended diet and exercise plan
Patients who need a lower-cost option may begin with oral medications and transition to GLP-1 therapy later if financially feasible
NAEs were identified using SOC = nervous system disorders (SOC ID: 10,029,205) and primary SOC = Yes, encompassing 1075 PTs from MedDRA version 27.0
You may hesitate to bring it up with your doctor or feel that it's somehow cheating to get help from prescription drugs